HMG-CoA reductase drugs for Atherosclerotic Cardiovascular Disease
3 tracked HMG-CoA reductase drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the HMG-CoA reductase page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
1 approved / phase 41 Phase 21 preclinical / unstaged